Spatial single-cell omics: new insights into liver diseases
-
By
-
Yuan Suo
-
Robert Thimme
-
Bertram Bengsch
-
June 1, 2026
-
Clinical Scorecard: Advancements in Spatial Single-Cell Omics: Enhanced Understanding of Liver Disorders
At a Glance
| Category | Detail |
|---|
| Condition | Liver Disorders |
| Key Mechanisms | Spatial organization of liver microarchitecture and cell–cell interactions |
| Target Population | Patients with liver diseases |
| Care Setting | Clinical and research settings |
Key Highlights
- Spatial omics technologies enhance understanding of liver physiology and pathology.
- Integration of single-cell sequencing with spatial methods reveals zonal functional differences.
- Spatial features improve patient stratification and clinical decision-making.
Guideline-Based Recommendations
Diagnosis
- Utilize spatial omics for improved diagnostic procedures in liver diseases.
Management
- Incorporate spatial profiling technologies in the development of novel drug targets.
Monitoring & Follow-up
- Monitor spatial features of the liver microenvironment for personalized medicine.
Risks
- Consider challenges associated with spatial omics technologies in clinical applications.
Patient & Prescribing Data
Individuals diagnosed with various liver disorders
Spatial omics can guide personalized treatment strategies.
Clinical Best Practices
- Employ spatial omics for comprehensive understanding of liver disease mechanisms.
- Integrate findings from spatial technologies into clinical decision-making.
References
